Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
CVS HEALTH Corp roe for the quarter ending 2026-06-30 was 6.13%, a 5.65% increase year-over-year.
CVS HEALTH Corp roe for the quarter ending 2026-03-31 was 3.75%, a 45.02% decline year-over-year.
CVS HEALTH Corp roe for the quarter ending 2025-12-31 was 2.30%, a 62.15% decline year-over-year.
CVS HEALTH Corp roe for the quarter ending 2025-09-30 was 0.59%, a 91.22% decline year-over-year.
CVS HEALTH Corp roe for fiscal 2025 was 2.30%, a 62.15% decline from fiscal 2024.
CVS HEALTH Corp roe for fiscal 2024 was 6.07%, a 44.54% decline from fiscal 2023.
CVS HEALTH Corp roe for fiscal 2023 was 10.94%, a 80.76% increase from fiscal 2022.
CVS HEALTH Corp roe for fiscal 2022 was 6.05%, a 43.11% decline from fiscal 2021.